Healthcare provider profile · identity verified

Mangala Yeturu, M.D.

Internal Medicine · CHICAGO, IL · NPI 1912010125

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	946	288
Atorvastatin Calcium	Atorvastatin Calcium	865	265
Metoprolol Succinate	Metoprolol Succinate	345	102
Metformin Hcl	Metformin Hcl	298	89
Losartan Potassium	Losartan Potassium	277	84
Hydrochlorothiazide	Hydrochlorothiazide	276	86
Lisinopril	Lisinopril	268	73
Furosemide	Furosemide	218	70
Allopurinol	Allopurinol	204	62
Gabapentin	Gabapentin	202	65
Simvastatin	Simvastatin	201	61
Levothyroxine Sodium	Levothyroxine Sodium	198	61
Carvedilol	Carvedilol	166	53
Rosuvastatin Calcium	Rosuvastatin Calcium	161	57
Albuterol Sulfate Hfa	Albuterol Sulfate	139	51
Spironolactone	Spironolactone	135	37
Eliquis	Apixaban	124	32
Potassium Chloride	Potassium Chloride	122	45
Glipizide	Glipizide	119	31
Glimepiride	Glimepiride	116	34
Triamcinolone Acetonide	Triamcinolone Acetonide	112	45
Metoprolol Tartrate	Metoprolol Tartrate	110	35
Pantoprazole Sodium	Pantoprazole Sodium	107	39
Omeprazole	Omeprazole	106	35
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	33
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	95	23
Fluticasone Propionate	Fluticasone Propionate	91	40
Jardiance	Empagliflozin	88	23
Metformin Hcl Er	Metformin Hcl	86	33
Ezetimibe	Ezetimibe	81	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	20
Alendronate Sodium	Alendronate Sodium	70	21
Famotidine	Famotidine	68	23
Clopidogrel	Clopidogrel Bisulfate	66	17
Valsartan	Valsartan	65	21
Pravastatin Sodium	Pravastatin Sodium	62	21
Hydralazine Hcl	Hydralazine Hcl	61	20
Enalapril Maleate	Enalapril Maleate	60	12
Lovastatin	Lovastatin	57	18
Nifedipine Er	Nifedipine	57	20
Irbesartan	Irbesartan	53	15
Entresto	Sacubitril/Valsartan	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	17
Olmesartan Medoxomil	Olmesartan Medoxomil	52	15
Ozempic	Semaglutide	52	17
Baclofen	Baclofen	49	19
Januvia	Sitagliptin Phosphate	47	suppressed
Glipizide Er	Glipizide	43	14
Klor-Con M20	Potassium Chloride	42	12
Lorazepam	Lorazepam	42	12
Montelukast Sodium	Montelukast Sodium	41	15
Xarelto	Rivaroxaban	41	suppressed
Tramadol Hcl	Tramadol Hcl	40	21
Chlorthalidone	Chlorthalidone	39	12
Meclizine Hcl	Meclizine Hcl	39	15
Tamsulosin Hcl	Tamsulosin Hcl	39	14
Alprazolam	Alprazolam	38	12
Telmisartan	Telmisartan	38	suppressed
Methimazole	Methimazole	37	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Celecoxib	Celecoxib	36	13
Duloxetine Hcl	Duloxetine Hcl	36	11
Diclofenac Sodium	Diclofenac Sodium	34	17
Torsemide	Torsemide	34	11
Benazepril Hcl	Benazepril Hcl	30	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Meloxicam	Meloxicam	29	17
Azithromycin	Azithromycin	28	25
Prednisone	Prednisone	28	24
Trazodone Hcl	Trazodone Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Atenolol	Atenolol	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Amoxicillin	Amoxicillin	24	23
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Felodipine Er	Felodipine	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Colchicine	Colchicine	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	18	suppressed
Indapamide	Indapamide	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Rybelsus	Semaglutide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Lactulose	Lactulose	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Metolazone	Metolazone	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Clonidine	Clonidine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Temazepam	Temazepam	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Niacin Er	Niacin	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error